Céline Narjoz

Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues

Ivan Bièche, Céline Narjoz, Tarik Asselah et al. · Pharmacogenetics and Genomics · 2007 · 340 citations

Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin

Isabelle Gouin‐Thibault, Xavier Delavenne, Anne Blanchard et al. · Journal of Thrombosis and Haemostasis · 2016 · 139 citations · Full text

Health Sciences, Antibiotics, Abcb1 Genetic Polymorphisms +15

<i><scp>UGT</scp>1A1</i> genotype and irinotecan therapy: general review and implementation in routine practice

Marie-Christine Étienne-Grimaldi, Jean‐Christophe Boyer, Fabienne Thomas et al. · Fundamental and Clinical Pharmacology · 2015 · 108 citations

Pathology, Pharmacotherapy, Advanced Colorectal Cancer +20

Early Sorafenib-Induced Toxicity Is Associated with Drug Exposure and UGTIA9 Genetic Polymorphism in Patients with Solid Tumors: A Preliminary Study

Pascaline Boudou‐Rouquette, Céline Narjoz, Jean Louis Golmard et al. · PLoS ONE · 2012 · 99 citations · Full text

APOL1 Polymorphisms and Development of CKD in an Identical Twin Donor and Recipient Pair

Tomek Kofman, Vincent Audard, Céline Narjoz et al. · American Journal of Kidney Diseases · 2014 · 64 citations · Full text

Allelic Variant, Human Leukocyte Antigen, Recipient Pair +9